Mexamine Injection Im/Iv 500Mcg/1Ml

Product Overview

Product Form: Injection (IM/IV)
Pack Size: 1ml
Manufactured By: ASIAN CONTINENTAL PHARMACEUTICALS
Prescription Required: Yes

Product Details

Mexamine Injection IM/IV 500mcg/1ml contains Mecobalamin, a bioactive form of Vitamin B12. It plays a crucial role in nerve health and the production of red blood cells. Mecobalamin is transported to nerve cells more efficiently than other forms of Vitamin B12, aiding in the synthesis of methionine from homocysteine and promoting nucleic acid and protein synthesis. This makes Mexamine Injection particularly effective in treating megaloblastic anemia and peripheral neuropathies caused by Vitamin B12 deficiency.

Purposes

The primary purpose of Mexamine Injection IM/IV 500mcg/1ml is to treat Vitamin B12 deficiencies that lead to anemia and nerve damage. It is also used in conditions that affect nerve function, such as peripheral neuropathies. The mecobalamin in Mexamine Injection enhances the repair and regeneration of damaged nerves and supports overall nerve health, making it beneficial in various neurological conditions.

Warnings

• Optic Nerve Damage: If you have a history of Leber’s disease or other optic nerve damage, consult your healthcare provider before using Mexamine Injection IM/IV 500mcg/1ml.
• Iron or Folic Acid Deficiency: Inform your doctor if you have any iron or folic acid deficiencies, as these conditions may require additional treatments alongside mecobalamin.
• Medication Disclosure: Always share a complete list of your medications with your doctor and pharmacist to avoid potential interactions.

Adverse Effects

Mexamine Injection IM/IV 500mcg/1ml is generally well-tolerated. However, some users may experience mild side effects such as gastrointestinal discomfort, nausea, diarrhea, or skin rashes. If any adverse reactions persist or worsen, contact your healthcare provider. Severe allergic reactions are rare but should be reported immediately if they occur.

Cautions

Mexamine Injection IM/IV 500mcg/1ml should not be used over extended periods if there is no visible improvement in conditions such as megaloblastic anemia or peripheral neuropathies. Regular monitoring of the patient’s response to the treatment is essential for achieving the best outcomes. Always follow your healthcare provider's guidance regarding dosage and duration of treatment.